Lilly Antibody Drug Prevents Covid-19 in Nursing Homes, Study Finds

The drugmaker plans to ask U.S. health regulators to expand bamlanivimab’s use to protect nursing-home residents and staff from Covid-19.

Source: Reuters: Health - January 21, 2021 Category: Consumer Health News Source Type: news